Details of issuance or disposal
Exercise status of the 10th Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause)
450,000 new shares (transferred treasury shares: 0 shares)
The lower thin line represents the existing number of shares to which these shares will be added.
Total amount to be paid: Not disclosed; estimated net proceeds: Not disclosed
Exercise ratio subject to exercise restrictions: 4.6% (450,000 shares delivered / 9,828,480 listed shares outstanding at issuance)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise status of the 10th Series Stock Acquisition Rights issued through a third-party allotment (with exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 450,000 new shares (transferred treasury shares: 0 shares) |
| Issue price and disposal price | Exercise price: ¥142–¥173 per share |
| Amount of funds to be raised | Total amount to be paid: Not disclosed; estimated net proceeds: Not disclosed |
| Intended allottee | EVO FUND (82,700 rights) |
| Dilution Rate | Exercise ratio subject to exercise restrictions: 4.6% (450,000 shares delivered / 9,828,480 listed shares outstanding at issuance) |
| Total number of issued shares | 9,838,500 shares (as of the end of the month preceding the relevant month) → 10,288,500 shares (simple calculation) |
| Exercise price | The exercise price during the relevant month was ¥142–¥173 per share. Details of the adjustment clause and the floor price: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 82,700 rights; exercised during the relevant month: 4,500 rights; unexercised at the end of the relevant month: 78,100 rights |
| Most recent equity financing | Timing 13 February 2026 / Type Issuance of the 10th Series Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status of the stock acquisition rights.